BrightSpring Health Services, Inc. (BTSG)
NASDAQ: BTSG · Real-Time Price · USD
47.42
+0.15 (0.32%)
Apr 20, 2026, 2:57 PM EDT - Market open

Company Description

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States.

The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis.

The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021.

BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

BrightSpring Health Services, Inc.
BrightSpring Health Services logo
CountryUnited States
Founded1974
IPO DateJan 26, 2024
IndustryHealth Information Services
SectorHealthcare
Employees23,500
CEOJon Rousseau

Contact Details

Address:
805 North Whittington Parkway
Louisville, Kentucky 40222
United States
Phone502 394 2100
Websitebrightspringhealth.com

Stock Details

Ticker SymbolBTSG
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$13.00
CIK Code1865782
CUSIP Number10950A106
ISIN NumberUS10950A1060
Employer ID82-2956404
SIC Code8082

Key Executives

NamePosition
Jon B. RousseauChairman, President and Chief Executive Officer
Lisa NalleyChief of Staff and Senior Vice President of Human Resources
Mike McMaudeConsultant
Jennifer A. PhippsChief Financial Officer, Executive Vice President and Corporate Secretary
Jennifer YowlerSenior Vice President of Sales and Account Management
Rachael Kurzer GivensChief Compliance Officer
Daryn DemerittSenior Vice President of Government Relations
Dr. William Mills M.D.Senior Vice President of Medical Affairs
Scott Greenwell Pharm.D.Executive Vice President and President of PharMerica

Latest SEC Filings

DateTypeTitle
Apr 10, 2026ARSFiling
Apr 10, 2026DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 10, 2026DEF 14AOther definitive proxy statements
Apr 7, 2026SCHEDULE 13G/AFiling
Mar 31, 20268-KCurrent Report
Mar 26, 2026SCHEDULE 13G/AFiling
Mar 4, 2026SCHEDULE 13D/AFiling
Mar 4, 20268-KCurrent Report
Mar 3, 2026424B7Filing
Mar 2, 2026424B7Filing